PeptideStack
5.2kquestions
20kanswers
220users

Does aggregation dominate for cagrilintide held at 25 °C?

Asked 28 Mar 2024Modified 2.2 years agoViewed 56k times
34

Setup, so nobody has to ask: aggregation · cagrilintide · 25 °C.

I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious.

My background is quantitative but not chemical, so I can follow an equation more easily than a hand-wave.

Why does this happen, and what would falsify the usual explanation?

peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questions
hplc
hplc

Reverse-phase high-performance liquid chromatography, the workhorse purity method. Column chemistry, mobile-phase choice, gradient slope,…

503 questions
amylin
amylin

Amylin and its analogues, most prominently cagrilintide, as a satiety mechanism orthogonal to incretin signalling. Includes the pharmacology of…

237 questions
shareeditfollowflag
HC
askedhaze_check9.3k1628 Mar 2024
8What temperature, and for how long? Both are needed before anyone can say anything useful. – bac_or_bust 20 days ago
7Do you know the residual moisture? It predicts this better than any date does. – helena_vidmar 9 months ago
add a comment

5 Answers

Accepted answer first, then by votes
140

Accepted answer

At 25 °C the question is which route is fastest, not whether aggregation happens — and the routes do not share an activation energy, so their ranking changes with temperature. 25 °C is 20 kelvin above the 5 °C middle of a 2–8 °C refrigerator. The ten-degree rule of thumb — degradation rate roughly doubling per 10 K — makes that about 4 times the refrigerated rate, which is an order-of-magnitude statement and not a shelf life. That multiplier is an average over every route at once, which is exactly why it cannot tell you which one wins. Molecules associate without any covalent change, so the mass is unchanged and a reversed-phase run — which is performed in organic solvent — mostly dissolves the evidence before it can be measured. So the way to answer it for your vial is to pick the method that sees aggregation specifically and run it against a control held cold, rather than to infer a mechanism from a purity number that averages all of them.

Start with the sequence, because which pathways are available depends on which residues are present.

Oxidation targets methionine, cysteine and tryptophan, adding sixteen daltons per oxygen. It is catalysed by trace metals and promoted by dissolved oxygen and by light.

A mass spectrum resolves most of this: minus eighteen is dehydration or succinimide, plus one is deamidation, plus sixteen is oxidation, and an unchanged mass with a shifted retention time is an isomer.

Metal-catalysed oxidation of methionine is documented across peptide and protein formulations and is why chelators appear in some formulations.

Nothing here is medical advice, and research-use compounds are not approved for human use.

At dilute concentrations, suspect adsorption before you suspect chemistry.

shareimprove this answerflag
DB
answered · acceptedDr_Ingrid_Baumgartner73k5817 Apr 2024
7I have kept vials both ways for a year and this matches what I saw. – deamidation_watch 3 months ago
6Thank you — this is the answer I was looking for. – Dr_Lena_Ostrowska 1 months ago
add a comment
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
55

The honest answer is that most reported "degradation" is adsorption and dilution error rather than chemistry.

Aggregation is physical: peptides unfold at air-liquid interfaces and associate. Shaking maximises that interface, which is why swirling and shaking produce visibly different outcomes on the same vial.

In practice, hydrolysis cleaves the backbone, most readily at aspartate-proline and aspartate-glycine sequences, and is acid-catalysed. In a dry solid it barely proceeds at all.

Aggregation at air-liquid interfaces is established from surface-tension and particle-count studies and is the basis for anti-agitation handling guidance.

The caveat is that none of these pathways can be seen by looking at a vial, and a clear solution can be substantially degraded.

A mass spectrum names the pathway. Plus one, plus sixteen, minus eighteen.

shareimprove this answerflag
TG
answeredtandem_gradient61k24828 Apr 2024
44

The short version: water enables most of it, oxygen enables oxidation, surfaces enable adsorption, and agitation enables aggregation.

Freeze-thaw cycling drives aggregation through concentration at the ice interface and pH shifts as buffer components crystallise out at different rates. Each cycle costs something.

Deamidation converts asparagine or glutamine to the corresponding acid via a succinimide intermediate, adding one dalton. It is base-catalysed, accelerates above neutral pH and is the dominant aqueous pathway for many peptides.

Apparent loss in a dilute preparation is usually adsorption rather than degradation and is worth ruling out first.

Sequence decides which pathways are even available. Check the residues.

edited 20 May 2024 by Dr_Bram_Verhoeven — added the method parameters

shareimprove this answerflag
DV
answeredDr_Bram_Verhoeven84k2489 May 2024
35

Mechanically, this is answerable from the chemistry rather than from anecdote, which is unusual and welcome.

Adsorption onto glass and plastic is significant at low concentrations — micrograms per millilitre — and negligible at milligrams per millilitre. It is the usual explanation for an apparent loss in a dilute preparation.

Adsorption losses at low concentrations are quantified in formulation studies and are the reason carrier proteins are used in dilute preparations.

Sequence determines which pathways apply, so general statements are general.

Cold, dry, dark, still. Those four words cover most of the mitigation.

shareimprove this answerflag
RC
answeredRP_C18105k34820 May 2024
3I would add a sentence about light, since tryptophan-containing sequences care. – mz_4113 32 days ago
add a comment
26

On the detail: asparagine and glutamine are the deamidation risk, and methionine is the oxidation risk.

Light exposure matters for tryptophan-containing sequences and for anything with a chromophore. Amber vials and a closed box are free mitigations.

Deamidation via the succinimide intermediate is well characterised, with sequence-dependent rates highest for asparagine-glycine motifs.

The caveat is that "within specification" and "unchanged" are different claims. A vial can lose a few per cent of content and still be usable for its purpose while no longer matching its certificate.

Swirl, never shake. Aggregation is a handling problem more than a time problem.

shareimprove this answerflag
SH
answeredseven_day_half31k13831 May 2024
6The desiccant point is under-appreciated and costs nothing to act on. – two_point_four 9 months ago
5Small correction: it is the number of cycles rather than the freezer temperature that does the damage. – Dr_Bram_Verhoeven 8 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.